journal
MENU ▼
Read by QxMD icon Read
search

Circulation. Heart Failure

journal
https://www.readbyqxmd.com/read/28615368/editor-s-note
#1
EDITORIAL
James E Udelson
No abstract text is available yet for this article.
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28615367/patient-perceptions-on-facilitating-follow-up-after-heart-failure-hospitalization
#2
Khadijah Breathett, Rachel D'Amico, T M Ayodele Adesanya, Stefanie Hatfield, Shannon Willis, Rodney X Sturdivant, Randi E Foraker, Sakima Smith, Philip Binkley, William T Abraham, Pamela N Peterson
BACKGROUND: Timely follow-up after hospitalization for heart failure (HF) is recommended. However, follow-up is suboptimal, especially in lower socioeconomic groups. Patient-centered solutions for facilitating follow-up post-HF hospitalization have not been extensively evaluated. METHODS AND RESULTS: Face-to-face surveys were conducted between 2015 and 2016 among 83 racially diverse adult patients (61% African American, 34% Caucasian, and 5% Other) hospitalized for HF at a university hospital centered in a low-income area of Columbus, Ohio...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28615366/significance-of-ischemic-heart-disease-in-patients-with-heart-failure-and-preserved-midrange-and-reduced-ejection-fraction-a-nationwide-cohort-study
#3
Ola Vedin, Carolyn S P Lam, Angela S Koh, Lina Benson, Tiew Hwa Katherine Teng, Wan Ting Tay, Oscar Ö Braun, Gianluigi Savarese, Ulf Dahlström, Lars H Lund
BACKGROUND: The pathogenic role of ischemic heart disease (IHD) in heart failure (HF) with reduced ejection fraction (HFrEF; EF <40%) is well established, but its pathogenic and prognostic significance in HF with midrange (HFmrEF; EF 40%-50%) and preserved EF (HFpEF; EF ≥50%) has been much less explored. METHODS AND RESULTS: We evaluated 42 987 patients from the Swedish Heart Failure Registry with respect to baseline IHD, outcomes (IHD, HF, cardiovascular events, and all-cause death), and EF change during a median follow-up of 2...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611130/precision-medicine-for-heart-failure-lessons-from-oncology
#4
Arthur M Feldman, Christopher D Kontos, Joseph M McClung, Glenn S Gerhard, Kamel Khalili, Joseph Y Cheung
No abstract text is available yet for this article.
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611129/microvascular-paradigm-in-heart-failure-with-preserved-ejection-fraction-a-quest-for-proof-of-concept
#5
EDITORIAL
Mark T Waddingham, Walter J Paulus
No abstract text is available yet for this article.
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611128/decreased-kcne2-expression-participates-in-the-development-of-cardiac-hypertrophy-by-regulation-of-calcineurin-nfat-nuclear-factor-of-activated-t-cells-and-mitogen-activated-protein-kinase-pathways
#6
Wenjuan Liu, Jianxin Deng, Wenwen Ding, Gang Wang, Yuanyuan Shen, Junmeng Zheng, Xiaoming Zhang, Yizhi Luo, Chifei Lv, Yonghui Wang, Liqing Chen, Dewen Yan, Ryan L Boudreau, Long-Sheng Song, Jie Liu
BACKGROUND: KCNE2 is a promiscuous auxiliary subunit of voltage-gated cation channels. A recent work demonstrated that KCNE2 regulates L-type Ca(2+) channels. Given the important roles of altered Ca(2+) signaling in structural and functional remodeling in diseased hearts, this study investigated whether KCNE2 participates in the development of pathological hypertrophy. METHODS AND RESULTS: We found that cardiac KCNE2 expression was significantly decreased in phenylephrine-induced cardiomyocyte hypertrophy in neonatal rat ventricular myocytes and in transverse aortic constriction-induced cardiac hypertrophy in mice, as well as in dilated cardiomyopathy in human...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611127/pulmonary-hypertension-is-associated-with-a-higher-risk-of-heart-failure-hospitalization-and-mortality-in-patients-with-chronic-kidney-disease-the-jackson-heart-study
#7
Senthil Selvaraj, Sanjiv J Shah, Mark J Ommerborn, Cheryl R Clark, Michael E Hall, Robert J Mentz, Saadia Qazi, Jeremy M Robbins, Thomas N Skelton, Jiaying Chen, J Michael Gaziano, Luc Djoussé
BACKGROUND: African Americans develop chronic kidney disease and pulmonary hypertension (PH) at disproportionately high rates. Little is known whether PH heightens the risk of heart failure (HF) admission or mortality among chronic kidney disease patients, including patients with non-end-stage renal disease. METHODS AND RESULTS: We analyzed African Americans participants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min per 1.73 m(2) or urine albumin/creatinine >30 mg/g) and available echocardiogram-derived pulmonary artery systolic pressure (PASP) from the Jackson Heart Study (N=408)...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611126/patient-reported-health-related-quality-of-life-is-a-predictor-of-outcomes-in-ambulatory-heart-failure-patients-treated-with-left-ventricular-assist-device-compared-with-medical-management-results-from-the-roadmap-study-risk-assessment-and-comparative-effectiveness
#8
Josef Stehlik, Jerry D Estep, Craig H Selzman, Joseph G Rogers, John A Spertus, Keyur B Shah, Joyce Chuang, David J Farrar, Randall C Starling
BACKGROUND: The prospective observational ROADMAP study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management) demonstrated that ambulatory advanced heart failure patients selected for left ventricular assist device (LVAD) were more likely to be alive at 1 year on original therapy with ≥75-m improvement in 6-minute walk distance compared with patients assigned to optimal medical management. Whether baseline health-related quality of life (hrQoL) resulted in a heterogeneity of this treatment benefit is unknown...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611125/design-and-rationale-of-the-phase-3-attr-act-clinical-trial-tafamidis-in-transthyretin-cardiomyopathy-clinical-trial
#9
Mathew S Maurer, Perry Elliott, Giampaolo Merlini, Sanjiv J Shah, Márcia Waddington Cruz, Alison Flynn, Balarama Gundapaneni, Carolyn Hahn, Steven Riley, Jeffrey Schwartz, Marla B Sultan, Claudio Rapezzi
Transthyretin amyloidosis is a rare, life-threatening disease resulting from aggregation and deposition of transthyretin amyloid fibrils in various tissues. There are 2 predominate phenotypic presentations of the disease: transthyretin familial amyloid polyneuropathy, which primarily affects the peripheral nerves, and transthyretin cardiomyopathy (TTR-CM), which primarily affects the heart. However, there is a wide overlap with symptoms at presentation and disease course being highly variable and influenced by the underlying transthyretin mutation, age of the affected individual, sex, and geographic location...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611124/endothelial-senescence-contributes-to-heart-failure-with-preserved-ejection-fraction-in-an-aging-mouse-model
#10
Andreas B Gevaert, Hadis Shakeri, Arthur J Leloup, Cor E Van Hove, Guido R Y De Meyer, Christiaan J Vrints, Katrien Lemmens, Emeline M Van Craenenbroeck
BACKGROUND: Because of global aging, the prevalence of heart failure with preserved ejection fraction (HFpEF) continues to rise. Although HFpEF pathophysiology remains incompletely understood, endothelial inflammation is stated to play a central role. Cellular senescence is a process of cellular growth arrest linked with aging and inflammation. We used mice with accelerated aging to investigate the role of cellular senescence in HFpEF development. METHODS AND RESULTS: Senescence-accelerated mice (SAM, n=18) and control mice with normal senescence (n=15) were fed normal chow or a high-fat, high-salt diet (WD)...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28611123/sex-differences-in-mortality-based-on-united-network-for-organ-sharing-status-while-awaiting-heart-transplantation
#11
Eileen M Hsich, Eugene H Blackstone, Lucy Thuita, Dennis M McNamara, Joseph G Rogers, Hemant Ishwaran, Jesse D Schold
BACKGROUND: There are sex differences in mortality while awaiting heart transplantation, and the reason remains unclear. METHODS AND RESULTS: We included all adults in the Scientific Registry of Transplant Recipients placed on the heart transplant active waitlist from 2004 to 2015. The primary end point was all-cause mortality. Multivariable Cox proportional hazards models were performed to evaluate survival by United Network for Organ Sharing (UNOS) status at the time of listing...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28607153/2017-acc-aha-hfsa-ishlt-acp-advanced-training-statement-on-advanced-heart-failure-and-transplant-cardiology-revision-of-the-accf-aha-acp-hfsa-ishlt-2010-clinical-competence-statement-on-management-of-patients-with-advanced-heart-failure-and-cardiac-transplant
#12
REVIEW
Mariell Jessup, Mark H Drazner, Wendy Book, Joseph C Cleveland, Ira Dauber, Susan Farkas, Mahazarin Ginwalla, Jason N Katz, Peggy Kirkwood, Michelle M Kittleson, Joseph E Marine, Paul Mather, Alanna A Morris, Donna M Polk, Antoine Sakr, Kelly H Schlendorf, Esther E Vorovich
No abstract text is available yet for this article.
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28588021/accelerometer-measured-daily-activity-in-heart-failure-with-preserved-ejection-fraction-clinical-correlates-and-association-with-standard-heart-failure-severity-indices
#13
David Snipelisky, Jacob Kelly, James A Levine, Gabriel A Koepp, Kevin J Anstrom, Steven E McNulty, Rosita Zakeri, G Michael Felker, Adrian F Hernandez, Eugene Braunwald, Margaret M Redfield
BACKGROUND: Daily physical activity assessed by accelerometers represents a novel method to assess the impact of interventions on heart failure (HF) patients' functional status. We hypothesized that daily activity varies by patient characteristics and correlates with established measures of HF severity in HF with preserved ejection fraction. METHODS AND RESULTS: In this ancillary study of the NEAT-HFpEF trial (Nitrate's Effects on Activity Tolerance in HF With Preserved Ejection Fraction), average daily accelerometer units (ADAU) and hours active per day were assessed during a 14-day period before starting isosorbide mononitrate or placebo (n=110)...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28572214/impact-of-preeclampsia-on-clinical-and-functional-outcomes-in-women-with-peripartum-cardiomyopathy
#14
Kathryn J Lindley, Shayna N Conner, Alison G Cahill, Eric Novak, Douglas L Mann
BACKGROUND: Preeclampsia is a risk factor for the development of peripartum cardiomyopathy (PPCM), but it is unknown whether preeclampsia impacts clinical or left ventricular (LV) functional outcomes. This study sought to assess clinical and functional outcomes in women with PPCM complicated by preeclampsia. METHODS AND RESULTS: This retrospective cohort study included women diagnosed with PPCM delivering at Barnes-Jewish Hospital between 2004 to 2014. The primary outcome was one-year event-free survival rate for the combined end point of death and hospital readmission...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28572213/cardiorespiratory-fitness-and-reclassification-of-risk-for-incidence-of-heart-failure-the-veterans-exercise-testing-study
#15
Jonathan Myers, Peter Kokkinos, Khin Chan, Eshan Dandekar, Bilge Yilmaz, Atul Nagare, Charles Faselis, Muhammad Soofi
BACKGROUND: It is well established that cardiorespiratory fitness (CRF) is inversely associated with cardiovascular and all-cause mortality. However, little is known regarding the association between CRF and incidence of heart failure (HF). METHODS AND RESULTS: Between 1987 and 2014, we assessed CRF in 21 080 HF-free subjects (58.3±11 years) at the Veterans Affairs Medical Centers in Washington, DC, and Palo Alto, CA. Subjects were classified by age-specific quintiles of CRF...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28559418/abnormal-global-longitudinal-strain-predicts-future-deterioration-of-left-ventricular-function-in-heart-failure-patients-with-a-recovered-left-ventricular-ejection-fraction
#16
Luigi Adamo, Andrew Perry, Eric Novak, Majesh Makan, Brian R Lindman, Douglas L Mann
BACKGROUND: Patients with recovery of left ventricular ejection fraction (LVEF) remain at risk for future deterioration of LVEF. However, there are no tools to risk stratify these patients. We hypothesized that global longitudinal strain (GLS) could predict sustained recovery within this population. METHODS AND RESULTS: We retrospectively identified 96 patients with a reduced LVEF <50% (screening echocardiogram), whose LVEF had increased by at least 10% and normalized (>50%) on evidence-based medical therapies (baseline echocardiogram)...
June 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28500255/balancing-bleeding-and-clotting-the-known-unknowns-of-mechanically-assisted-circulation
#17
EDITORIAL
Joseph G Rogers
No abstract text is available yet for this article.
May 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28500254/increased-thromboembolic-events-with-dabigatran-compared-with-vitamin-k-antagonism-in-left-ventricular-assist-device-patients-a-randomized-controlled-pilot-trial
#18
Martin Andreas, Roxana Moayedifar, Georg Wieselthaler, Michael Wolzt, Julia Riebandt, Thomas Haberl, Philipp Angleitner, Thomas Schlöglhofer, Dominik Wiedemann, Heinrich Schima, Guenther Laufer, Daniel Zimpfer
BACKGROUND: Left ventricular assist device-supported patients are usually anticoagulated with a combination of aspirin and vitamin K antagonists. Long-term vitamin K antagonist therapy can be complicated by unstable international normalized ratio values and patient-related compliance problems. Therefore, direct thrombin inhibitors may represent an alternative to vitamin K antagonists. METHODS AND RESULTS: Thirty HeartWare ventricular assist device patients with stable renal function were planned for this prospective, randomized, open-label, single-center study...
May 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28495954/the-heavy-heart-metabolic-mechanisms-and-myocardial-mechanics
#19
EDITORIAL
Amanda R Vest, Ayan R Patel
No abstract text is available yet for this article.
May 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28495953/cardiometabolic-traits-and-systolic-mechanics-in-the-community
#20
Jennifer E Ho, Elizabeth L McCabe, Thomas J Wang, Martin G Larson, Daniel Levy, Connie Tsao, Jayashri Aragam, Gary F Mitchell, Emelia J Benjamin, Ramachandran S Vasan, Susan Cheng
BACKGROUND: Obesity and cardiometabolic dysfunction are associated with increased risk of heart failure and other cardiovascular diseases. We sought to examine the association of cardiometabolic traits with left ventricular (LV) cardiac mechanics. We hypothesized that specific obesity-related phenotypes are associated with distinct aspects of LV strain. METHODS AND RESULTS: We evaluated the associations of obesity-related phenotypes, including central adiposity, diabetes mellitus, insulin resistance, and circulating adipokine concentrations with echocardiographic measures of LV mechanical function among participants of the Framingham Heart Study Offspring and Third Generation cohorts...
May 2017: Circulation. Heart Failure
journal
journal
42092
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"